# EDGAR Filing Document

**Accession Number:** 0001810747
**File Stem:** 0000940400-25-011476
**Filing Date:** 2025-11
**Character Count:** 33652
**Document Hash:** a7f18eb9dba1f27554ca50a0d0fe8924
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-25-011476.hdr.sgml**: 20251128

**ACCESSION NUMBER**: 0000940400-25-011476

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251128

**DATE AS OF CHANGE**: 20251128

**PERIOD START**: 20260630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Simplify Exchange Traded Funds
- **CENTRAL INDEX KEY:** 0001810747

**ORGANIZATION NAME:**
- **EIN:** 851887571
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23570
- **FILM NUMBER:** 251534466

**BUSINESS ADDRESS:**
- **STREET 1:** 222 BROADWAY
- **STREET 2:** 22ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10038
- **BUSINESS PHONE:** 646-741-2438

**MAIL ADDRESS:**
- **STREET 1:** 222 BROADWAY
- **STREET 2:** 22ND FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10038

## Series and Classes Contracts Data

### Simplify Health Care ETF (Series ID: S000073751)

| Class ID   | Class Name               | Ticker Symbol   |
|:---|:---|:---|
| C000230898 | Simplify Health Care ETF | PINK            |

## Nport-Ex

#### Simplify

#### Health

#### Care

#### ETF

#### Schedule

#### of

#### Investments
September

30,

2025

(Unaudited)

#### Shares

#### Value

#### Common

#### Stocks

#### –

#### 97.2%

#### Consumer

#### Discretionary

#### –

#### 3.9%
Chewy,

Inc.,

Class

A\*

......................................................

7,277

$

294,355

National

Vision

Holdings,

Inc.\*

...............................................

197,840

5,774,949

6,069,304

#### Health

#### Care

#### –

#### 88.1%
Abbott

Laboratories

........................................................

11,138

1,491,824

AbbVie,

Inc.

..............................................................

36,883

8,539,890

Abivax

SA,

ADR\*

..........................................................

61,449

5,217,020

agilon

health,

Inc.\*

.........................................................

113,976

117,395

Alignment

Healthcare,

Inc.\*

.................................................

136,934

2,389,498

Apellis

Pharmaceuticals,

Inc.\*

................................................

106,888

2,418,875

Arcutis

Biotherapeutics,

Inc.\*

................................................

317,997

5,994,243

Argenx

SE,

ADR\*

.........................................................

1,659

1,223,612

AstraZeneca

PLC,

ADR

....................................................

36,944

2,834,344

Benitec

Biopharma,

Inc.\*

....................................................

78,725

1,104,512

Biohaven

Ltd.\*

............................................................

109,685

1,646,372

Boston

Scientific

Corp.\*

....................................................

8,087

789,534

Bristol-Myers

Squibb

Co.

...................................................

596

26,880

Cardinal

Health,

Inc.

.......................................................

12,223

1,918,522

Cencora,

Inc.

.............................................................

7,406

2,314,597

Cigna

Group

(The)

........................................................

1,746

503,284

Cooper

Cos.,

Inc.

(The)\*

....................................................

7,088

485,953

CVS

Health

Corp.

.........................................................

83,740

6,313,159

Danaher

Corp.

............................................................

8,079

1,601,743

Edwards

Lifesciences

Corp.\*

................................................

10,054

781,900

Eli

Lilly

&

Co.

.............................................................

9,664

7,373,632

Embecta

Corp.

...........................................................

1,575

22,223

Establishment

Labs

Holdings,

Inc.\*

...........................................

37,948

1,555,489

Eyepoint

Pharmaceuticals,

Inc.\*

..............................................

90,440

1,287,866

Fulcrum

Therapeutics,

Inc.\*

.................................................

83,234

765,753

GE

HealthCare

Technologies,

Inc.

............................................

28,184

2,116,618

GeneDx

Holdings

Corp.,

Class

A\*

............................................

15,362

1,655,102

Gilead

Sciences,

Inc.

......................................................

60,186

6,680,646

Guardant

Health,

Inc.\*

......................................................

30,254

1,890,270

HealthEquity,

Inc.\*

.........................................................

15,805

1,497,840

ICON

PLC\*

..............................................................

827

144,725

Insmed,

Inc.\*

.............................................................

18,384

2,647,480

Intuitive

Surgical,

Inc.\*

......................................................

7,640

3,416,837

IQVIA

Holdings,

Inc.\*

.......................................................

9,044

1,717,817

Johnson

&

Johnson

........................................................

11,402

2,114,159

Leap

Therapeutics,

Inc.\*

....................................................

975,608

442,926

Ligand

Pharmaceuticals,

Inc.\*

...............................................

6,786

1,202,072

LivaNova

PLC\*

...........................................................

9,691

507,615

Merus

NV\*

...............................................................

33,314

3,136,513

Mineralys

Therapeutics,

Inc.\*

................................................

218,726

8,294,090

Nektar

Therapeutics\*

......................................................

59,174

3,367,001

Neurocrine

Biosciences,

Inc.\*

................................................

36,624

5,141,277

Pacira

BioSciences,

Inc.\*

...................................................

44,946

1,158,258

Penumbra,

Inc.\*

..........................................................

8,101

2,052,145

Praxis

Precision

Medicines,

Inc.\*

.............................................

10,812

#### Simplify

#### Health

#### Care

#### ETF

#### Schedule

#### of

#### Investments
(Continued)

September

30,

2025

(Unaudited)

#### Shares

#### Value

#### Common

#### Stocks
(continued)

#### Health

#### Care
(continued)

Regeneron

Pharmaceuticals,

Inc.

.............................................

12,981

$

7,298,827

Revvity,

Inc.

..............................................................

16,418

1,439,038

Sarepta

Therapeutics

Inc\*

...................................................

4,119

79,373

Stryker

Corp.

.............................................................

1,242

459,130

Syndax

Pharmaceuticals,

Inc.\*

...............................................

28,505

438,549

Teleflex,

Inc.

.............................................................

751

91,892

TG

Therapeutics,

Inc.\*

.....................................................

11,525

416,341

Thermo

Fisher

Scientific,

Inc.

................................................

2,435

1,181,024

United

Therapeutics

Corp.\*

..................................................

19,920

8,350,663

UnitedHealth

Group,

Inc.

....................................................

28,618

9,881,795

Vertex

Pharmaceuticals,

Inc.\*

................................................

1,225

479,759

Zimmer

Biomet

Holdings,

Inc.

................................................

2,314

227,929

138,256,643

#### Industrials

#### –

#### 0.3%
3M

Co.

..................................................................

1,769

274,513

Fluor

Corp\*

..............................................................

3,292

138,495

Veralto

Corp.

.............................................................

46,056

459,064

#### Materials

#### –

#### 4.9%
PureCycle

Technologies,

Inc.\*

...............................................

590,609

7,766,508

Total

Common

Stocks

(Cost

$137,762,458)

.........................................

152,551,519

#### Money

#### Market

#### Fund

#### –

#### 1.4%
Dreyfus

Treasury

Obligations

Cash

Management

Fund,

Institutional

Shares,

4.00%(a)

(Cost

$2,262,510)

.......................................................

2,262,510

2,262,510

#### U.S.

#### Exchange-Traded

#### Funds

#### –

#### 1.4%

#### Equity

#### Funds

#### –

#### 1.4%
AdvisorShares

Pure

US

Cannabis

ETF\*

(Cost

$2,195,629)

.......................................................

444,428

2,128,810

Total

Investments

–

100.0%

(Cost

$142,220,597)

...........................................................

$

156,942,839

Liabilities

in

Excess

of

Other

Assets

–

(0.0)%†

........................................

(4,397)

#### Net

#### Assets

#### –

#### 100.0%

#### ............................................................

#### $

#### 156,938,442
\*

Non

Income

Producing

†

Less

than

0.05%

(a) Rate

shown

reflects

the

7-day

yield

as

of

September

30,

2025. ADR

:

American

Depositary

Receipt

#### Simplify

#### Health

#### Care

#### ETF

#### Schedule

#### of

#### Investments
(Continued)

September

30,

2025

(Unaudited)

#### Summary

#### of

#### Investment

#### Type††

#### Investment

#### Categories

#### %

#### of

#### Net

#### Assets
Common

Stocks

..............................................................................

97.2%

Money

Market

Fund

...........................................................................

1.4%

U.S.

Exchange-Traded

Funds

....................................................................

1.4%

Total

Investments

.............................................................................

100.0%

Liabilities

in

Excess

of

Other

Assets

...............................................................

(0.0)%†

#### Net

#### Assets

#### ..................................................................................

#### 100.0%
†

Less

than

0.05%

††

The

percentage

shown

for

each

investment

category

is

the

total

value

of

investments

in

that

category

as

a

percentage

of

the

net

assets

of

the

Fund.

The

table

depicts

the

Fund's

investments

but

may

not

represent

the

Fund's

market

exposure

to

certain

derivatives,

if

any,

which

are

included

in

Liabilities

in

Excess

of

Other

Assets.

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Simplify Exchange Traded Funds

- **b. Investment Company Act file number:** 811-23570

- **c. CIK number of Registrant:** 0001810747

- **d. LEI of Registrant:** 549300LDDEMEUCZQEO55

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 10845 Griffith Peak Drive

  - **City:** Las Vegas

  - **State:** NV

  - **Foreign country:** US

  - **Zip / Postal Code:** 89135

  - **Telephone number:** (702) 389-9705

**Item A.2. Information about the Series.**

- **a. Name of Series:** Simplify Health Care ETF

- **b. EDGAR series identifier (if any):** S000073751

- **c. LEI of Series:** 549300WPEU6YIKEJVH06

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-06-30

- **b. Date as of which information is reported:** 2025-09-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $156994063.60

**Total Liabilities:** $55622.53

**Net Assets:** $156938441.07

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000230898 | -2.99%               | 4.78%                | 4.08%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $1675444.15              | $-5536485.59                               |
| Month 2  | $-1925793.04             | $7825647.56                                |
| Month 3  | $-732211.44              | $6243295.97                                |

### Schedule of Portfolio Investments

| Name                               | Title                              | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| AbbVie Inc                         | AbbVie Inc                         | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |     36883 | NS      | $8539889.82   | 5.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corp          | Edwards Lifesciences Corp          | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |     10054 | NS      | $781899.58    | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Cardinal Health Inc                | Cardinal Health Inc                | CUSIP: 14149Y108<br>LEI: CCU46N3GJMF4OK4N7U60 | Long             | EC               | CORP              | US        |     12223 | NS      | $1918522.08   | 1.22%             |  |  |  | No            |                  1 | On Loan: No      |
| IQVIA Holdings Inc                 | IQVIA Holdings Inc                 | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |      9044 | NS      | $1717817.36   | 1.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Teleflex Inc                       | Teleflex Inc                       | CUSIP: 879369106<br>LEI: UUL85LWXB4NGSWWXIQ25 | Long             | EC               | CORP              | US        |       751 | NS      | $91892.36     | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| ICON PLC                           | ICON PLC                           | CUSIP: 000000000<br>LEI: 6354008SRQGEMC4XFI67 | Long             | EC               | CORP              | IE        |       827 | NS      | $144725.00    | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc             | UnitedHealth Group Inc             | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |     28618 | NS      | $9881795.40   | 6.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                     | Eli Lilly & Co                     | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      9664 | NS      | $7373632.00   | 4.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Mineralys Therapeutics Inc         | Mineralys Therapeutics Inc         | CUSIP: 603170101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    218726 | NS      | $8294089.92   | 5.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Insmed Inc                         | Insmed Inc                         | CUSIP: 457669307<br>LEI: 529900Q55QAG41CCAC11 | Long             | EC               | CORP              | US        |     18384 | NS      | $2647479.84   | 1.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Praxis Precision Medicines Inc     | Praxis Precision Medicines Inc     | CUSIP: 74006W207<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       204 | NS      | $10812.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                       | Danaher Corp                       | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |      8079 | NS      | $1601742.54   | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacira BioSciences Inc             | Pacira BioSciences Inc             | CUSIP: 695127100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     44946 | NS      | $1158258.42   | 0.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                | Guardant Health Inc                | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     30254 | NS      | $1890269.92   | 1.20%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Inc         | Ligand Pharmaceuticals Inc         | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |      6786 | NS      | $1202072.04   | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                  | Johnson & Johnson                  | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |     11402 | NS      | $2114158.84   | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Fluor Corp                         | Fluor Corp                         | CUSIP: 343412102<br>LEI: CQ7WZ4NOFWT7FAE6Q943 | Long             | EC               | CORP              | US        |      3292 | NS      | $138494.44    | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical Inc             | Intuitive Surgical Inc             | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |      7640 | NS      | $3416837.20   | 2.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc      | Regeneron Pharmaceuticals Inc      | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     12981 | NS      | $7298826.87   | 4.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Neurocrine Biosciences Inc         | Neurocrine Biosciences Inc         | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |     36624 | NS      | $5141277.12   | 3.28%             |  |  |  | No            |                  1 | On Loan: No      |
| DREYFUS TRSY OBLIG CASH M          | DREYFUS TRSY OBLIG CASH M          | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |   2262510 | NS      | $2262509.73   | 1.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Syndax Pharmaceuticals Inc         | Syndax Pharmaceuticals Inc         | CUSIP: 87164F105<br>LEI: 529900OF94TRHKZVBS87 | Long             | EC               | CORP              | US        |     28505 | NS      | $438549.43    | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc         | Zimmer Biomet Holdings Inc         | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |      2314 | NS      | $227929.00    | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| agilon health Inc                  | agilon health Inc                  | CUSIP: 00857U107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    113976 | NS      | $117395.28    | 0.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Penumbra Inc                       | Penumbra Inc                       | CUSIP: 70975L107<br>LEI: 549300RGE06P3ECANU72 | Long             | EC               | CORP              | US        |      8101 | NS      | $2052145.32   | 1.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc       | Thermo Fisher Scientific Inc       | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |      2435 | NS      | $1181023.70   | 0.75%             |  |  |  | No            |                  1 | On Loan: No      |
| GE HealthCare Technologies Inc     | GE HealthCare Technologies Inc     | CUSIP: 36266G107<br>LEI: 549300OI9J7XOWZMUN85 | Long             | EC               | CORP              | US        |     28184 | NS      | $2116618.40   | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| TG Therapeutics Inc                | TG Therapeutics Inc                | CUSIP: 88322Q108<br>LEI: 529900X21UKABN9NJ529 | Long             | EC               | CORP              | US        |     11525 | NS      | $416340.63    | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Leap Therapeutics Inc              | Leap Therapeutics Inc              | CUSIP: 52187K200<br>LEI: 549300T31SMMJ2DDLI13 | Long             | EC               | CORP              | US        |    975608 | NS      | $442926.03    | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Arcutis Biotherapeutics Inc        | Arcutis Biotherapeutics Inc        | CUSIP: 03969K108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    317997 | NS      | $5994243.45   | 3.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Alignment Healthcare Inc           | Alignment Healthcare Inc           | CUSIP: 01625V104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    136934 | NS      | $2389498.30   | 1.52%             |  |  |  | No            |                  1 | On Loan: No      |
| 3M Co                              | 3M Co                              | CUSIP: 88579Y101<br>LEI: LUZQVYP4VS22CLWDAR65 | Long             | EC               | CORP              | US        |      1769 | NS      | $274513.42    | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc         | Vertex Pharmaceuticals Inc         | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |      1225 | NS      | $479759.00    | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp           | United Therapeutics Corp           | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     19920 | NS      | $8350663.20   | 5.32%             |  |  |  | No            |                  1 | On Loan: No      |
| EyePoint Pharmaceuticals Inc       | EyePoint Pharmaceuticals Inc       | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |     90440 | NS      | $1287865.60   | 0.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp             | Boston Scientific Corp             | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |      8087 | NS      | $789533.81    | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Fulcrum Therapeutics Inc           | Fulcrum Therapeutics Inc           | CUSIP: 359616109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     83234 | NS      | $765752.80    | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Sarepta Therapeutics Inc           | Sarepta Therapeutics Inc           | CUSIP: 803607100<br>LEI: 549300IKDPIED8J8IG21 | Long             | EC               | CORP              | US        |      4119 | NS      | $79373.13     | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| LivaNova PLC                       | LivaNova PLC                       | CUSIP: 000000000<br>LEI: 2138001K2FX6SHK2B339 | Long             | EC               | CORP              | GB        |      9691 | NS      | $507614.58    | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics                | Nektar Therapeutics                | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |     59174 | NS      | $3367000.60   | 2.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Cigna Group/The                    | Cigna Group/The                    | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |      1746 | NS      | $503284.50    | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Chewy Inc                          | Chewy Inc                          | CUSIP: 16679L109<br>LEI: 254900NPQSTG9I422879 | Long             | EC               | CORP              | US        |      7277 | NS      | $294354.65    | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos Inc/The                 | Cooper Cos Inc/The                 | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |      7088 | NS      | $485953.28    | 0.31%             |  |  |  | No            |                  1 | On Loan: No      |
| PureCycle Technologies Inc         | PureCycle Technologies Inc         | CUSIP: 74623V103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    590609 | NS      | $7766508.35   | 4.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                | Abbott Laboratories                | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |     11138 | NS      | $1491823.72   | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Benitec Biopharma Inc              | Benitec Biopharma Inc              | CUSIP: 08205P209<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     78725 | NS      | $1104511.75   | 0.70%             |  |  |  | No            |                  1 | On Loan: No      |
| Stryker Corp                       | Stryker Corp                       | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |      1242 | NS      | $459130.14    | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Embecta Corp                       | Embecta Corp                       | CUSIP: 29082K105<br>LEI: 549300RPG8GXVDHNXZ62 | Long             | EC               | CORP              | US        |      1575 | NS      | $22223.25     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| HealthEquity Inc                   | HealthEquity Inc                   | CUSIP: 42226A107<br>LEI: 529900LRJU1RAFQHM467 | Long             | EC               | CORP              | US        |     15805 | NS      | $1497839.85   | 0.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co            | Bristol-Myers Squibb Co            | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |       596 | NS      | $26879.60     | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                | Gilead Sciences Inc                | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |     60186 | NS      | $6680646.00   | 4.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Revvity Inc                        | Revvity Inc                        | CUSIP: 714046109<br>LEI: 549300IKL1SDPFI7N655 | Long             | EC               | CORP              | US        |     16418 | NS      | $1439037.70   | 0.92%             |  |  |  | No            |                  1 | On Loan: No      |
| GeneDx Holdings Corp               | GeneDx Holdings Corp               | CUSIP: 81663L200<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     15362 | NS      | $1655101.88   | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                    | AstraZeneca PLC                    | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |     36944 | NS      | $2834343.68   | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Abivax SA                          | Abivax SA                          | CUSIP: 00370M103<br>LEI: 969500D8TMNB184OJU95 | Long             | EC               | CORP              | FR        |     61449 | NS      | $5217020.10   | 3.32%             |  |  |  | No            |                  1 | On Loan: No      |
| National Vision Holdings Inc       | National Vision Holdings Inc       | CUSIP: 63845R107<br>LEI: 549300JHURCBLI5ROA42 | Long             | EC               | CORP              | US        |    197840 | NS      | $5774949.60   | 3.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                       | Biohaven Ltd                       | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    109685 | NS      | $1646371.85   | 1.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Merus NV                           | Merus NV                           | CUSIP: 000000000<br>LEI: 549300W8GPUWU8QNU293 | Long             | EC               | CORP              | NL        |     33314 | NS      | $3136513.10   | 2.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Cencora Inc                        | Cencora Inc                        | CUSIP: 03073E105<br>LEI: AI8GXW8LG5WK7E9UD086 | Long             | EC               | CORP              | US        |      7406 | NS      | $2314597.18   | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| AdvisorShares Pure US Cannabis ETF | AdvisorShares Pure US Cannabis ETF | CUSIP: 00768Y453<br>LEI: 549300U1LLTOEUUI7S22 | Long             | EC               | RF                | US        |    444428 | NS      | $2128810.12   | 1.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Veralto Corp                       | Veralto Corp                       | CUSIP: 92338C103<br>LEI: 635400FJE6GSOJUSNY27 | Long             | EC               | CORP              | US        |       432 | NS      | $46055.52     | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Establishment Labs Holdings In     | Establishment Labs Holdings Inc    | CUSIP: 000000000<br>LEI: 549300BCBQ714JNJ7V58 | Long             | EC               | CORP              | CR        |     37948 | NS      | $1555488.52   | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                          | Argenx SE                          | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |      1659 | NS      | $1223612.04   | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS Health Corp                    | CVS Health Corp                    | CUSIP: 126650100<br>LEI: 549300EJG376EN5NQE29 | Long             | EC               | CORP              | US        |     83740 | NS      | $6313158.60   | 4.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Apellis Pharmaceuticals Inc        | Apellis Pharmaceuticals Inc        | CUSIP: 03753U106<br>LEI: 254900HS0ZFRXXSB9D42 | Long             | EC               | CORP              | US        |    106888 | NS      | $2418875.44   | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-11-26

**Name of Applicant:** Simplify Exchange Traded Funds

**Signature:** Paul Kim

**Name of Signer:** Paul Kim

**Title:** Trustee & President